Exact Therapeutics AS (EXTX) — Financial Flexibility Index
Exact Therapeutics AS (EXTX) has a Financial Flexibility Index of -2.10x as of December 2024. Free cash flow of Nkr-79.04 Million (operating CF Nkr-80.55 Million minus capex Nkr1.51 Million) represents -2% of total liabilities (Nkr37.65 Million). Also explore EXTX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Exact Therapeutics AS Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Exact Therapeutics AS across 8 annual periods. Check strategic asset allocation of Exact Therapeutics AS to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Exact Therapeutics AS (2017–2024)
Year-by-year free cash flow to debt coverage for Exact Therapeutics AS. For the full company profile including market capitalisation, see EXTX market cap.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.10x | Nkr-79.04 Million | Nkr-80.55 Million | Nkr37.65 Million | ▲ +17.4% |
| 2023 | -2.54x | Nkr-41.20 Million | Nkr-44.30 Million | Nkr16.22 Million | ▼ -31.6% |
| 2022 | -1.93x | Nkr-33.60 Million | Nkr-33.85 Million | Nkr17.40 Million | ▲ +57.1% |
| 2021 | -4.50x | Nkr-53.48 Million | Nkr-55.11 Million | Nkr11.89 Million | ▼ -116.1% |
| 2020 | -2.08x | Nkr-22.03 Million | Nkr-25.99 Million | Nkr10.58 Million | ▼ -85.7% |
| 2019 | -1.12x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr9.87 Million | ▲ +37.5% |
| 2018 | -1.79x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr6.17 Million | ▼ -89.2% |
| 2017 | -0.95x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr11.68 Million | — |